OBJECTIVES:: The aim of this study is to establish an association with organizational factors related to the health insurance and outcomes of disease activity of RA in Colombia. METHODS:: The real world observed results of DAS28 were estimated using the number of patients with a diagnosis of RA obtained in the period or earlier, who were cared for in the national health system between 2015 and 2016 receiving treatment with DMARD in the period, available in the High-Cost disease office. Using an ordered logit regression model, we used administrative records of days since symptoms to diagnose, use of Rheumatoid Factor (RF) and anti-citrullinated antibodies (ACPA), physician or specialist involved in care, type of insurance and care facilities. This dataset allow determinate the association between outcomes of disease activity and relevant topics of insurance. RESULTS:: A total of 68247 registries of patients were analyzed, and only the 39% had measured for DAS28 in this period. From the 3709 incidents patients, just the 27% had ACPA, and 76% had RF to confirm the diagnosis, 27 % have cared in a specialized center. There were significate differences associated with better outcomes in RA management; the results show a decrease by level disease’s activity. ACPA (p=0.059) decrease 0.23 log odds, physician involved -1 (p=0.001), type of insurance -0.62 (p=0.002), Specialized Center -0.4 (p=0.000). CONCLUSIONS:: There are several issues related to the outcome of patients with RA besides of DMARD therapy. Type of insurance linked to specialized care centers, physicians involved in care, and labs authorizations, which are intimately associated with impact results in those patients. It was found a positive association between certain administrative activities and DAS28 results; however, given the sub-registry of time and labs variables, these findings must be regarded carefully by stakeholders.